Data / Drug companies / Injection, suspension
Companies that list injection, suspension products: 75 companies and 266 products in the FDA NDC directory
The FDA National Drug Code Directory lists 266 products that are injection, suspension products from 75 companies. The ten largest listers hold 47.4% of them, and the newest started marketing on November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 75Companies
- 266Products
- 36Drugs by generic name
- Biologics (BLA)Main marketing category
Companies that list injection, suspension products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 25 | injection, suspension | Biologics (BLA) | October 21, 2021 |
| Amneal Pharmaceuticals LLC | 16 | injection, suspension | Generic drugs (ANDA) | November 10, 2023 |
| Eli Lilly and Company | 15 | injection, suspension | Biologics (BLA) | February 12, 2020 |
| Merck Sharp & Dohme LLC | 15 | injection, suspension | Biologics (BLA) | July 16, 2021 |
| Sanofi Vaccines US Inc. | 12 | injection, suspension | Biologics (BLA) | August 27, 2026 |
| Asclemed USA, Inc. | 9 | injection, suspension | Other unapproved drugs | November 19, 2019 |
| Pharmacia & Upjohn Company LLC | 9 | injection, suspension | New drug applications (NDA) | May 2, 2005 |
| Sportpharm LLC | 9 | injection, suspension | Generic drugs (ANDA) | July 1, 2026 |
| GlaxoSmithKline Biologicals SA | 8 | injection, suspension | Biologics (BLA) | December 1, 2016 |
| Novo Nordisk | 8 | injection, suspension | Biologics (BLA) | September 6, 2019 |
| Eugia US LLC | 6 | injection, suspension | Generic drugs (ANDA) | April 13, 2023 |
| Pfizer Laboratories Div Pfizer Inc | 6 | injection, suspension | New drug applications (NDA) | May 18, 1953 |
| Alkermes, Inc. | 5 | injection, suspension | Drugs for further processing | April 13, 2006 |
| Gland Pharma Limited | 5 | injection, suspension | Generic drugs (ANDA) | November 2, 2026 |
| Bamboo US Bidco LCC | 4 | injection, suspension | Biologics (BLA) | August 1, 2026 |
| Bavarian Nordic A/s | 4 | injection, suspension | Biologics (BLA) | March 1, 2025 |
| Dr. Reddy's Laboratories Inc. | 4 | injection, suspension | Generic drugs (ANDA) | October 20, 2025 |
| Moderna US, Inc. | 4 | injection, suspension | Biologics (BLA) | August 17, 2026 |
| Mylan Institutional LLC | 4 | injection, suspension | Generic drugs (ANDA) | May 8, 2023 |
| Pfizer Laboratories Div Pfizer Inc | 4 | injection, suspension | Biologics (BLA) | August 27, 2026 |
| Remedyrepack Inc. | 4 | injection, suspension | Generic drugs (ANDA) | March 9, 2026 |
| Alembic Pharmaceuticals Inc. | 3 | injection, suspension | Generic drugs (ANDA) | October 17, 2025 |
| Alembic Pharmaceuticals Limited | 3 | injection, suspension | Generic drugs (ANDA) | October 17, 2025 |
| American Regent, Inc. | 3 | injection, suspension | Generic drugs (ANDA) | November 1, 2019 |
| Amneal Pharmaceuticals NY LLC | 3 | injection, suspension | Generic drugs (ANDA) | June 10, 2025 |
| E.r. Squibb & Sons, L.L.C. | 3 | injection, suspension | New drug applications (NDA) | April 12, 2019 |
| Eli Lilly Italia Spa | 3 | injection, suspension | Drugs for further processing | February 9, 2024 |
| NorthStar Rx LLC | 3 | injection, suspension | Generic drugs (ANDA) | November 19, 2019 |
| Novartis Pharmaceuticals Corporation | 3 | injection, suspension | Biologics (BLA) | October 1, 2024 |
| Sagent Pharmaceuticals | 3 | injection, suspension | Generic drugs (ANDA) | March 1, 2026 |
| Advanced Rx of Tennessee, LLC | 2 | injection, suspension | Generic drugs (ANDA) | July 26, 2023 |
| Alloga Logstica Espaa S.L. | 2 | injection, suspension | Drugs for further processing | August 20, 2024 |
| Amgen, Inc | 2 | injection, suspension | Biologics (BLA) | November 2, 2015 |
| Asclemed USA Inc. | 2 | injection, suspension | Generic drugs (ANDA) | July 1, 2026 |
| Caplin Steriles Limited | 2 | injection, suspension | Generic drugs (ANDA) | February 6, 2026 |
| Idt Biologika GmbH | 2 | injection, suspension | Drugs for further processing | February 1, 2022 |
| Jubilant HollisterStier LLC | 2 | injection, suspension | Drugs for further processing | February 5, 2013 |
| Lantheus Medical Imaging, Inc. | 2 | injection, suspension | New drug applications (NDA) | October 1, 2020 |
| Novo Nordisk Pharma, Inc. | 2 | injection, suspension | Biologics (BLA) | September 11, 2002 |
| Patheon Manufacturing Services LLC | 2 | injection, suspension | Drugs for further processing | September 1, 2025 |
| Prasco Laboratories | 2 | injection, suspension | Authorized generics (NDA) | October 21, 2021 |
| Replimune, Inc. | 2 | injection, suspension | Biologics (BLA) | September 4, 2026 |
| Rovi Pharma Industrial Services S.A. | 2 | injection, suspension | Drugs for further processing | August 20, 2024 |
| Rovi Pharma Industrial Services SA | 2 | injection, suspension | Drugs for further processing | August 20, 2024 |
| Seqirus, Inc. | 2 | injection, suspension | Biologics (BLA) | July 1, 2026 |
| Sun Pharmaceutical Industries, Inc. | 2 | injection, suspension | Generic drugs (ANDA) | May 4, 2019 |
| Teva Parenteral Medicines, Inc. | 2 | injection, suspension | Generic drugs (ANDA) | August 29, 2019 |
| Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 2 | injection, suspension | Biologics (BLA) | August 10, 2021 |
| Bausch & Lomb Incorporated | 1 | injection, suspension | New drug applications (NDA) | December 17, 2021 |
| Cilag AG | 1 | injection, suspension | Drugs for further processing | January 21, 2021 |
| Eagle Pharmaceuticals, Inc. | 1 | injection, suspension | New drug applications (NDA) | July 23, 2014 |
| Emergent BioDefense Operations Lansing LLC | 1 | injection, suspension | Biologics (BLA) | November 4, 1970 |
| Emergent Product Development Gaithersburg Inc. | 1 | injection, suspension | Biologics (BLA) | September 19, 2023 |
| Harrow Eye, LLC | 1 | injection, suspension | New drug applications (NDA) | October 1, 2024 |
| Henogen | 1 | injection, suspension | Drugs for further processing | December 8, 2023 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, suspension | Generic drugs (ANDA) | March 3, 2025 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, suspension | Generic drugs (ANDA) | May 1, 2023 |
| Isomedix Operations Inc | 1 | injection, suspension | Drugs for further processing | July 23, 2014 |
| Janssen Biotech, Inc. | 1 | injection, suspension | Biologics (BLA) | February 28, 2022 |
| MSP Vaccine Company | 1 | injection, suspension | Biologics (BLA) | December 21, 2018 |
| Medexus Pharma, Inc. | 1 | injection, suspension | Unapproved drugs for a shortage | March 3, 2021 |
| Novartis Innovative Technologies Inc. | 1 | injection, suspension | Biologics (BLA) | November 24, 2025 |
| Organon LLC | 1 | injection, suspension | New drug applications (NDA) | June 1, 2021 |
| Patheon Italia S.p.A. | 1 | injection, suspension | Drugs for further processing | July 16, 2021 |
| Precigen, Inc. | 1 | injection, suspension | Biologics (BLA) | September 15, 2025 |
| Proficient Rx LP | 1 | injection, suspension | Generic drugs (ANDA) | August 29, 2019 |
| Proficient Rx LP | 1 | injection, suspension | New drug applications (NDA) | June 1, 2009 |
| Rocket Pharmaceuticals, Inc. | 1 | injection, suspension | Biologics (BLA) | March 26, 2026 |
| Samsung Biologics Co., Ltd. | 1 | injection, suspension | Drugs for further processing | November 17, 2020 |
| Ucb, Inc. | 1 | injection, suspension | New drug applications (NDA) | May 12, 2016 |
| Uswm CT, LLC | 1 | injection, suspension | Biologics (BLA) | August 2, 2024 |
| Valneva Scotland Ltd. | 1 | injection, suspension | Biologics (BLA) | March 30, 2009 |
| Vertex Pharmaceuticals Incorporated | 1 | injection, suspension | Biologics (BLA) | December 8, 2023 |
| Vetter Pharma Fertigung GmbH & Co. KG | 1 | injection, suspension | Biologics (BLA) | March 30, 2009 |
| Xiromed, LLC | 1 | injection, suspension | Generic drugs (ANDA) | March 12, 2024 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Triamcinolone acetonide | 54 | 77 |
| Medroxyprogesterone acetate | 18 | 23 |
| Brivaracetam | 1 | 17 |
| Dantrolene sodium | 1 | 14 |
| Methylprednisolone acetate | 36 | 10 |
| Hepatitis b vaccine (recombinant) | 10 | 4 |
| Insulin aspart | 10 | 4 |
| Insulin human | 4 | 4 |
| Insulin lispro | 4 | 4 |
| Betamethasone sodium phosphate and betamethasone acetate | 6 | 3 |
| Covid-19 vaccine, mrna | 7 | 2 |
| Human insulin | 5 | 2 |
| Hepatitis a vaccine | 4 | 2 |
| Penicillin g benzathine | 4 | 2 |
| Betamethasone acetate and betamethasone sodium phosphate | 2 | 2 |
| Hepatitis a and hepatitis b (recombinant) vaccine | 2 | 2 |
| Japanese encephalitis vaccine, inactivated, adsorbed | 2 | 2 |
| Hepatitis a vaccine, inactivated | 4 | 1 |
| Penicillin g benzathine and penicillin g procaine | 3 | 1 |
| Perflutren | 2 | 1 |
| Talimogene laherparepvec | 2 | 1 |
| Tisagenlecleucel | 2 | 1 |
| Vusolimogene oderparepvec-wtpg | 2 | 1 |
| Afamitresgene autoleucel | 1 | 1 |
| Anthrax vaccine adsorbed | 1 | 1 |
| Anthrax vaccine adsorbed, adjuvanted | 1 | 1 |
| Chikungunya vaccine, recombinant | 1 | 1 |
| Ciltacabtagene autoleucel | 1 | 1 |
| Exagamglogene autotemcel | 1 | 1 |
| Influenza vaccine, mrna | 1 | 1 |
| Marnetegragene autotemcel | 1 | 1 |
| Meningococcal group b vaccine | 1 | 1 |
| Nvx-cov2928 | 1 | 1 |
| Onasemnogene abeparvovec-brve | 1 | 1 |
| Triamcinolone hexacetonide | 1 | 1 |
| Zopapogene imadenovec | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.